EPS for Depomed, Inc. (DEPO) Expected At $-0.54

Retrieved on: 2018-04-21 11:22:30

Tags for this article:

Drugs

Assertio Therapeutics

Depo

Tapentadol

NASDAQ

Medroxyprogesterone acetate

S&P 500 INDEX - CBOE

Click the tags to see associated articles and topics

EPS for Depomed, Inc. (DEPO) Expected At $-0.54. View article details on hiswai:

Excerpt

<div>319,861 are held by <b>Aqr Capital Management</b> Lc. Metropolitan Life Ins Co has 0% invested in Depomed, Inc. (NASDAQ:DEPO). Regions has 0% invested in Depomed, Inc. (NASDAQ:DEPO). Glenmede Trust Na stated it has 355 shares or 0% of all its holdings. Hbk Invs L P has invested 0% in Depomed, ...</div>

Article found on:

View Original Article